|
시장보고서
상품코드
1964389
감염성 부르살병 백신 시장 규모, 점유율, 성장 분석 : 백신 유형별, 투여 경로별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Infectious Bursal Disease Vaccine Market Size, Share, and Growth Analysis, By Vaccine Type (Live Attenuated Vaccine, Inactivated Vaccine), By Administration Route (Injectable, Oral), By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 감염성 부르살병 백신 시장 규모는 2024년에 2억 9,000만 달러로 평가되었으며, 2025년 3억 1,349만 달러에서 2033년까지 5억 8,456만 달러로 성장할 전망입니다. 예측 기간(2026-2033년) 동안 CAGR은 8.1%로 예측됩니다.
세계 감염성 부르살병 백신 시장은 주로 가금류 생산의 성장과 세계화에 의해 주도되고 있습니다. 이는 사육 밀도의 증가와 국제 무역으로 인해 질병 전파 위험과 경제적 취약성이 높아졌기 때문입니다. 이 시장은 어린 닭의 면역력을 위협하고 심각한 생산 손실을 초래하는 전염성이 높은 바이러스 감염에 대응하는 백신에 대한 수요에 대응하기 위한 것입니다. 생산자들이 바이오 보안과 가금류의 건강을 우선시하는 가운데, 재조합 백신과 벡터 백신과 같은 기술적으로 진보된 백신 제제에 대한 수요가 증가하고 있습니다. 분자진단 기술의 혁신으로 돌연변이 균주를 조기에 발견할 수 있고, 인공지능(AI)은 공급망 데이터와 실시간 지식을 통합하여 수요 예측을 강화합니다. 규제 정합화와 가금류 통합 기업 및 생명공학 기업 간의 협력은 맞춤형 백신 솔루션의 길을 열어 시장 기회를 더욱 확대할 수 있습니다.
세계 감염성 부르살병 백신 시장의 촉진요인
전 세계 감염성 부르살병 백신 시장은 가금류 생산의 급속한 확대로 규모화, 집약화되는 양계장을 배경으로 성장하고 있습니다. 이러한 상황은 발생 위험을 높이고 농가와 가금류 통합 기업의 백신 전략 도입을 촉진하고 있습니다. 생산자들이 생산성과 제품 품질을 높이기 위해 동물의 건강을 중요하게 생각함에 따라 효과적인 예방접종에 대한 수요가 증가함에 따라 제조업체는 공급을 확대하고 맞춤형 백신 제제를 혁신해야 합니다. 생산 수요 증가와 예방적 건강 조치의 시너지 효과는 예방접종을 표준 농업 관행으로 확립할 뿐만 아니라, 유통망과 교육 이니셔티브에 대한 투자를 촉진하여 시장 확대를 촉진하고 있습니다.
세계 감염성 부르살병 백신 시장의 억제요인
전 세계 감염성 부르살병 백신 시장은 엄격한 온도 관리가 필요한 보관 및 취급 요건으로 인해 심각한 제약에 직면해 있습니다. 이러한 요구사항은 특히 외딴 지역이나 자원이 제한된 지역에서의 유통을 복잡하게 만들고, 물류 문제를 증가시킵니다. 신뢰할 수 있는 콜드체인 인프라에 의존하는 것은 공급업체에 큰 운영상의 부담을 주며, 편의성이나 제품 변질 위험을 우려하는 소규모 생산자들이 백신 접종을 주저하게 만들 수 있습니다. 이러한 유통 장벽은 지리적 접근을 제한하고, 공급망 관리를 복잡하게 만들며, 제조업체가 운송 및 보관 솔루션에 대한 막대한 투자 없이 다양한 농업 시스템에서 일관된 도입을 보장하는 것을 어렵게함으로써 시장 성장을 저해하고 있습니다.
세계 감염성 부르살병 백신 시장 동향
세계 감염성 부르살병 백신 시장에서는 재조합 기술과 새로운 백신 플랫폼으로의 전환이 눈에 띄게 진행되고 있으며, 이는 업계 혁신의 핵심이 되고 있습니다. 제조업체들은 안전성 프로파일 향상, 맞춤형 면역 반응, 효율적인 생산 워크플로우 등을 이유로 이러한 첨단 기술에 집중하고 있습니다. 이러한 플랫폼은 항원 특이적 제제 개발을 가능하게 하고, 질병 감시 전략과의 통합을 촉진하여 바이러스 변종으로 인한 진화하는 도전에 대응하는 데 있어 점점 더 다재다능한 플랫폼이 되고 있습니다. 그 결과, 다양한 가금류 집단에서 일관된 효능을 보장하면서 현대적 생산 관행에 부합하는 백신에 대한 수요가 증가함에 따라 확장 가능한 제조 시스템에 대한 투자와 생명공학 기업과 동물용 의약품 기업 간의 협력이 증가하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 감염성 부르살병 백신 시장 규모 : 백신 유형별 & CAGR(2026-2033년)
세계의 감염성 부르살병 백신 시장 규모 : 투여 경로별 & CAGR(2026-2033년)
세계의 감염성 부르살병 백신 시장 규모 : 최종사용자별 & CAGR(2026-2033년)
세계의 감염성 부르살병 백신 시장 규모 : 지역별 & CAGR(2026-2033년)
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.03.30Global Infectious Bursal Disease Vaccine Market size was valued at USD 290.0 Million in 2024 and is poised to grow from USD 313.49 Million in 2025 to USD 584.56 Million by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).
The global Infectious Bursal Disease Vaccine market is primarily driven by the growth and globalization of poultry production, which heightens risks of disease transmission and economic vulnerability due to increased flock density and international trade. This market caters to the need for vaccines that combat a highly contagious viral infection that threatens the immune competence of young chickens, leading to significant production losses. As producers prioritize biosecurity and flock health, there is a growing preference for technologically advanced vaccine formulations, such as recombinant and vectored products. Innovations in molecular diagnostics enable early detection of variant strains, while AI enhances demand forecasting by integrating supply chain data and real-time insights. Regulatory alignment and collaborations between poultry integrators and biotech firms further open avenues for tailored vaccine solutions and expanded market opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Infectious Bursal Disease Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Infectious Bursal Disease Vaccine Market Segments Analysis
Global infectious bursal disease vaccine market is segmented by vaccine type, administration route, end user and region. Based on vaccine type, the market is segmented into Live Attenuated Vaccine and Inactivated Vaccine. Based on administration route, the market is segmented into Injectable and Oral. Based on end user, the market is segmented into Poultry Farms, Research Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Infectious Bursal Disease Vaccine Market
The global market for Infectious Bursal Disease vaccines is driven by the rapid growth of poultry production, which leads to larger and more intensive flocks. This situation heightens the risk of outbreaks, prompting farmers and poultry integrators to increasingly adopt vaccination strategies. As producers emphasize animal health to enhance both productivity and product quality, the demand for effective immunization rises, urging manufacturers to broaden their supply and innovate customized vaccine formulations. This synergy between increasing production demands and preventive health measures not only solidifies vaccination as a standard farming practice but also promotes investments in distribution networks and educational initiatives, thereby bolstering market expansion.
Restraints in the Global Infectious Bursal Disease Vaccine Market
The Global Infectious Bursal Disease Vaccine market faces significant limitations due to the necessity for strict temperature-controlled storage and handling. This requirement complicates distribution, particularly in remote or resource-limited areas, and increases logistical challenges. The reliance on a reliable cold chain infrastructure places greater operational demands on suppliers, potentially discouraging smallholder producers from implementing vaccination practices due to concerns about convenience and the risk of product spoilage. These distribution barriers hinder market growth by restricting geographic access, complicating supply chain management, and making it difficult for manufacturers to ensure consistent adoption across various farming systems without considerable investments in transportation and storage solutions.
Market Trends of the Global Infectious Bursal Disease Vaccine Market
The Global Infectious Bursal Disease Vaccine market is experiencing a notable shift towards recombinant and novel vaccine platforms, which are becoming central to industry innovation. Manufacturers are focusing on these advanced technologies due to their enhanced safety profiles, customized immune responses, and efficient production workflows. These platforms enable the development of antigen-specific formulations and facilitate integration with disease surveillance strategies, making them increasingly versatile in addressing the evolving challenges posed by viral strains. Consequently, there's a rising investment in scalable manufacturing systems and collaborations between biotech and animal health companies, driven by the growing demand for vaccines that ensure consistent efficacy across diverse poultry populations while aligning with modern production practices.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
Global Infectious Bursal Disease Vaccine Market Size by Vaccine Type & CAGR (2026-2033)
- Market Overview
- Live Attenuated Vaccine
- Single Strain
- Multivalent
- Inactivated Vaccine
- Oil-based
- Water-based
Global Infectious Bursal Disease Vaccine Market Size by Administration Route & CAGR (2026-2033)
- Market Overview
- Injectable
- Intramuscular
- Subcutaneous
- Oral
- Liquid Formulation
- Tablet Formulation
Global Infectious Bursal Disease Vaccine Market Size by End User & CAGR (2026-2033)
- Market Overview
- Poultry Farms
- Commercial Farms
- Backyard Farms
- Research Institutions
- Veterinary Research
- Agricultural Research
- Others
Global Infectious Bursal Disease Vaccine Market Size & CAGR (2026-2033)
- North America (Vaccine Type, Administration Route, End User)
- US
- Canada
- Europe (Vaccine Type, Administration Route, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Vaccine Type, Administration Route, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Vaccine Type, Administration Route, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Vaccine Type, Administration Route, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Zoetis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elanco
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cegelec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hipra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intervet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vetoquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dechra Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neovia
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bioveta
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Axiota Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biopharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HyGentec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Liaoning Hile Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jinsha River Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chengdu Tiantai Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Indivior
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sihuan Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
